Clinical Trials Sponsored by Prove pharm

Total 6568 results

Prove pharm

Recruiting

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Patient's With Renal Impairment

Ureter Injury

United States
Prove pharm

Recruiting

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency

Ureter Injury

United States
Prove pharm

Completed

3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral Patency (UP)

Ureter Injury

United States
Hospital Quality Foundation
Prove pharm

Completed

Acquired Methemoglobinemia Observational Registry (metHb)

Methemoglobinemia | Methemoglobinemia, Acquired

United States
Gen-Probe, Incorporated

Terminated

Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays

Gonorrhea | Chlamydia Infections | Trichomonas Infections

United States
Gen-Probe, Incorporated

Completed

Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System

Human Papillomavirus Infection

United States
Gen-Probe, Incorporated

Withdrawn

Clinical Evaluation of the APTIMA® Assay for Chlamydia Trachomatis Using the PANTHER™ System

Chlamydia Trachomatis

United States
Gen-Probe, Incorporated

Completed

Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result (PCA3)

Prostatic Neoplasms

United States
Gen-Probe, Incorporated

Completed

Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay

HIV-1 Infection

United States
Gen-Probe, Incorporated

Completed

Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red Cross

Dengue

United States
Gen-Probe, Incorporated

Completed

Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTS

Dengue

United States
Gen-Probe, Incorporated

Completed

Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System

Chlamydia Trachomatis | Neisseria Gonorrhoeae Infection

United States
Proove Bioscience, Inc.

Unknown

Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management (MOSAIC)

Pain | Back Pain | Musculoskeletal Pain | Chronic Pain | Neck Pain | Neuropathic Pain | Pain, Intractable | Nociceptive Pain

United States
Proove Bioscience, Inc.

Unknown

A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care (REVOLUTION)

Mental Disorders | Cardiovascular Diseases | Pain | Diabetes Mellitus, Type 2 | Arthritis | Chronic Pain

United States
Gen-Probe, Incorporated

Completed

Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing

Trichomonas Vaginalis

United States
Gen-Probe, Incorporated

Completed

Prospective Collection of Female and Male Specimens for PANTHER® System Testing

Gonorrhea | Chlamydia Infections

United States
Gen-Probe, Incorporated

Completed

Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System

Human Papillomavirus Infection

United States
Gen-Probe, Incorporated

Completed

Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System

Human Papilloma Virus Infection

United States
Gen-Probe, Incorporated

Completed

APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results (AHPV-GT)

Human Papillomavirus Infection

United States
ViiV Healthcare
Evidera; mProve

Completed

Real-world Insights of People With Human Immunodeficiency Virus (HIV) Infection (RISE)

HIV Infections

United States
Prova Health Limited
Hoffmann-La Roche

Completed

A Remote Evaluation of NAVIFY Oncology Hub Using Clinical Simulation

Oncology

United Kingdom
University of Pittsburgh
Gen-Probe, Incorporated

Completed

Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing

Trichomonas Vaginitis | Chlamydia Trachomatis | Neisseria Gonorrhoeae Infection

United States
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
University of Florida
Florida Probe Corporation

Completed

The Impact of a Modified Probe Tip Design on Patient Perception of Discomfort on Probing and Clinical Parameters Using the Florida Probe® System

Periodontitis | Diagnoses Disease

United States
Centre for Probe Development and Commercialization

Completed

A Safety and Biodistribution Study of [I-124]-CPD-1028 Injection in Solid Tumours

Cancer

Canada
Shady Grove Fertility Reproductive Science Center

Unknown

Endometrial Biopsy Prior to IVF in Those Patients With Prior Implantation Failure (EMBX/IVF)

Infertility | Implantation Failure

United States
Shady Grove Fertility Reproductive Science Center

Completed

Study of Assisted Hatching of Cleavage Stage Embryos

Infertility

United States
Shady Grove Fertility Reproductive Science Center

Completed

Laser-Assisted Versus Conventional Intracytoplasmic Sperm Injection

Infertility | Infertility, Male

United States
Shady Grove Fertility Reproductive Science Center

Recruiting

Assessing Ketorolac (Toradol) at Oocyte Retrieval (Alleviate)

Infertility | Postoperative Pain | Infertility, Female | Embryo Transfer | Oocyte Retrieval

United States
Reproductive Science Center
Shady Grove Fertility

Completed

Use of Essure® Micro-inserts in Women With Hydrosalpinx Prior to In Vitro Fertilization: A Prospective, Multicenter, International Feasibility Study

Women Who Suffer From Hydrosalpinx That is Causing Infertility and Whom Want a Safer Way of Treamtent

United States
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
Shady Grove Fertility Reproductive Science Center
Igenomix

Unknown

Frozen Blastocyst Transfer Using Conventional Timing Versus Timing by Endometrial Receptivity Analysis (Synchrony)

Infertility, Female | Implantation Failure

United States
Proove Bioscience, Inc.
University of Southern California

Unknown

Observational Study Linking Genetic Variants With Clinical Outcomes in Pain Management (TROJAN)

Pain | Chronic Pain

United States
Shady Grove Fertility Reproductive Science Center
Ferring Pharmaceuticals

Completed

Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer

Infertility

United States
GE Healthcare
Centre for Probe Development and Commercialization

Completed

Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS).

Relapsing-remitting Multiple Sclerosis (rrMS)

Canada
Centre for Probe Development and Commercialization
McDougall Scientific Ltd.

Completed

Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer.

Recurrent Prostate Cancer | Prostate Cancer Recurrent

Canada
Ablon Skin Institute Research Center
Grove Acquisition Subsidiary dba VitaMedica

Recruiting

A Study to Evaluate the Efficacy and Safety of Clear Skin Formula on Mitigating Mild to Moderate Non-cystic Acne

Non-Cystic Acne

United States
UCB Biopharma S.P.R.L.
Pharm Research Associates (UK) Ltd.

Completed

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (BASE)

Epilepsy With POS With or Without Secondary Generalization

Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
R-Pharm Overseas, Inc.
R-Pharm; Data Management 365; Cromos Pharma LLC; Keystat, LLC; K-Research

Completed

Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 in Subjects With Acute ST-elevation Myocardial Infarction

Acute ST Segment Elevation Myocardial Infarction

United States, Russian Federation
R-Pharm

Completed

Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19

COVID-19

Russian Federation
R-Pharm

Completed

Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer

Neoplasms | Advanced Solid Tumors

United States
R-Pharm

Completed

Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies.

Solid Malignancies

United States
R-Pharm

Completed

Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

Breast Cancer | Metastases

Belgium, Spain, United States, Argentina, Brazil, Canada, Germany, Peru, Taiwan, United Kingdom, Italy, France, Korea, Republic of, Philippines, Thailand, Mexico, Sweden, China, Hungary, Poland, Greece, Malaysia
Yuria-Pharm

Unknown

Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Burns

Burns | Intoxication

Kazakhstan, Moldova, Republic of, Ukraine, Uzbekistan
Hyundai Pharm

Completed

Phase III Study to Evaluate the Efficacy and Safety of HOB-048 CR Tab. in Comparison With HOB-048 Syrup in Patients With Cough Due to Acute or Chronic Bronchitis

Evaluate the Efficacy and Safety of Levotuss CR Tab. in Comparison With Levotuss Syrup in Patients With Cough Due to Acute or Chronic Bronchitis

Korea, Republic of
R-Pharm

Terminated

A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer (IXAMPLE2)

Endometrial Cancer

Brazil, Czech Republic, Italy, Mexico, Russian Federation, Sweden, United Kingdom, United States, Spain, Canada, Denmark, France, Peru, Belgium, Hungary, Norway, Argentina, Australia, Greece
R-Pharm

Completed

Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies

Neoplasms | Advanced Solid Tumors

United States
R-Pharm

Completed

A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer

Breast Cancer

Japan

Clinical Trials Sponsored by Prove pharm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations